Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 8286248, 15 pages
https://doi.org/10.1155/2017/8286248
Research Article

Different Effects of Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-2 on Myogenic Differentiation of Human Mesenchymal Stem Cells

Doaa Aboalola1,2,3,4 and Victor K. M. Han1,2,3,5

1Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada
2Children’s Health Research Institute, University of Western Ontario, London, ON, Canada
3Lawson Health Research Institute, University of Western Ontario, London, ON, Canada
4King Abdullah International Medical Research Center, National Guard Health Affairs, Jeddah, Saudi Arabia
5Department of Paediatrics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada

Correspondence should be addressed to Victor K. M. Han; ac.no.cshl@nah.rotciv

Received 3 August 2017; Revised 28 September 2017; Accepted 10 October 2017; Published 14 December 2017

Academic Editor: Luca Vanella

Copyright © 2017 Doaa Aboalola and Victor K. M. Han. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. I. Jones and D. R. Clemmons, “Insulin-like growth factors and their binding proteins: biological actions,” Endocrine Reviews, vol. 16, no. 1, pp. 3–34, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. W. S. Cohick and D. R. Clemmons, “The insulin-like growth factors,” Annual Review of Physiology, vol. 55, pp. 131–153, 1993. View at Publisher · View at Google Scholar
  3. S. Shimasaki and N. Ling, “Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6),” Progress in Growth Factor Research, vol. 3, no. 4, pp. 243–266, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. L. A. Bach, S. J. Headey, and R. S. Norton, “IGF-binding proteins-the pieces are falling into place,” Trends in Endocrinology and Metabolism, vol. 16, no. 5, pp. 228–234, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Forbes and M. Westwood, “The IGF axis and placental function. A mini review,” Hormone Research, vol. 69, no. 3, pp. 129–137, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Baserga, A. Hongo, M. Rubini, M. Prisco, and B. Valentinis, “The IGF-I receptor in cell growth, transformation and apoptosis,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1332, no. 3, pp. F105–F126, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. K. W. Kim, S. K. Bae, O. H. Lee, M. H. Bae, M. J. Lee, and B. C. Park, “Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma,” Cancer Research, vol. 58, no. 2, pp. 348–351, 1998. View at Google Scholar
  8. R. Rubin and R. Baserga, “Insulin- like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity,” Laboratory Investigation, vol. 73, no. 3, pp. 311–331, 1995. View at Google Scholar
  9. M. A. Lawlor and P. Rotwein, “Coordinate control of muscle cell survival by distinct insulin-like growth factor activated signaling pathways,” The Journal of Cell Biology, vol. 151, no. 6, pp. 1131–1140, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. J. P. Liu, J. Baker, A. S. Perkins, E. J. Robertson, and A. Efstratiadis, “Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r),” Cell, vol. 75, no. 1, pp. 59–72, 1993. View at Publisher · View at Google Scholar
  11. L. Powell-Braxton, P. Hollingshead, C. Warburton et al., “IGF-I is required for normal embryonic growth in mice,” Genes & Development, vol. 7, no. 12B, pp. 2609–2617, 1993. View at Publisher · View at Google Scholar
  12. S. Jiao, Y. Li, J. Zhou, and L. Lu, “Differential regulation of IGF-I and IGF-II gene expression in skeletal muscle cells,” Molecular and Cellular Biochemistry, vol. 373, pp. 107–113, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Zanou and P. Gailly, “Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways,” Cellular and Molecular Life Sciences, vol. 70, no. 21, pp. 4117–4130, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Buckingham, “Skeletal muscle progenitor cells and the role of pax genes,” Comptes Rendus Biologies, vol. 330, no. 6-7, pp. 530–533, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. P. Lefaucheur and A. Sebille, “Muscle regeneration following injury can be modified in vivo by immune neutralization of basic fibroblast growth factor, transforming growth factor beta 1 or insulin-like growth factor I,” Journal of Neuroimmunology, vol. 57, no. 1-2, pp. 85–91, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. E. J. Carter, R. A. Cosgrove, I. Gonzalez et al., “MEK5 and ERK5 are mediators of the pro-myogenic actions of IGF-2,” Journal of Cell Science, vol. 122, Part 17, pp. 3104–3112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. E. M. Wilson, M. M. Hsieh, and P. Rotwein, “Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD stimulated myocyte maturation,” The Journal of Biological Chemistry, vol. 278, no. 42, pp. 41109–41113, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. A. Lawlor, X. Feng, D. R. Everding, K. Sieger, C. E. Stewart, and P. Rotwein, “Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways,” Molecular and Cellular Biology, vol. 20, no. 9, pp. 3256–3265, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Wang, Y. Liu, C. Wu et al., “The expression of IGFBP6 after spinal cord injury, implications for neuronal apoptosis,” Neurochemical Research, vol. 42, pp. 1–13, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. L. A. Bach, P. Fu, and Z. Yang, “Insulin-like growth factor-binding protein-6 and cancer,” Clinical Science, vol. 124, no. 4, pp. 215–229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. L. Leng, K. S. Leeding, R. H. Whitehead, and L. A. Bach, “Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced but not basal proliferation and adhesion of LIM 1215 colon cancer cells,” Molecular and Cellular Endocrinology, vol. 174, no. 1-2, pp. 121–127, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. L. A. Bach, “IGFBP-6 five years on; not so ‘forgotten’?” Growth Hormone & IGF Research, vol. 15, no. 3, pp. 185–192, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Cui, C. Ma, J. Qiu et al., “A novel interaction between insulin-like growth factor binding protein-6 and the vitamin D receptor inhibits the role of vitamin D3 in osteoblast differentiation,” Molecular and Cellular Endocrinology, vol. 338, no. 1-2, pp. 84–92, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. J. B. Janosi, P. A. Ramsland, M. R. Mott, S. M. Firth, R. C. Baxter, and P. J. Delhanty, “The acidlabile subunit of the serum insulin-like growth factor-binding protein complexes structural determination by molecular modeling and electron microscopy,” The Journal of Biological Chemistry, vol. 274, no. 33, pp. 23328–23332, 1999. View at Google Scholar
  25. R. G. Worton, E. A. McCulloch, and J. E. Till, “Physical separation of hemopoietic stem cells from cells forming colonies in culture,” Journal of Cellular Physiology, vol. 74, no. 2, pp. 171–182, 1969. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Aboalola and H. VKM, “Insulin-like growth factor binding protein-6 alters skeletal muscle differentiation of human mesenchymal stem cells,” Stem Cells International, vol. 2017, Article ID 2348485, 17 pages, 2017. View at Publisher · View at Google Scholar
  27. D. A. Hess, T. E. Meyerrose, L. Wirthlin et al., “Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity,” Blood, vol. 104, no. 6, pp. 1648–1655, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. B. J. Capoccia, D. L. Robson, K. D. Levac et al., “Revascularization of ischemic limbs by human bone marrow cells purified by aldehyde dehydrogenase activity,” Blood, vol. 113, no. 21, pp. 5340–5351, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. D. M. Putman, K. Y. Liu, H. C. Broughton, G. I. Bell, and D. A. Hess, “Umbilical cord blood-derived aldehyde dehydrogenase-expressing progenitor cells promote recovery from acute ischemic injury,” Stem Cells, vol. 30, no. 10, pp. 2248–2260, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Keller, “Embryonic stem cell differentiation: emergence of a new era in biology and medicine,” Genes & Development, vol. 19, no. 10, pp. 1129–1155, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. P. S. Anker, S. A. Scherjon, C. Kleijburg-van der Keur et al., “Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta,” Stem Cells, vol. 22, pp. 1338–1345, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Fukuchi, H. Nakajima, D. Sugiyama, I. Hirose, T. Kitamura, and K. Tsuji, “Human placenta-derived cells have mesenchymal stem/progenitor cell potential,” Stem Cells, vol. 22, no. 5, pp. 649–658, 2004. View at Publisher · View at Google Scholar
  33. Z. Miao, J. Jin, L. Chen et al., “Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells,” Cell Biology International, vol. 30, no. 9, pp. 681–687, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. O. Parolini, F. Alviano, G. P. Bagnara et al., “Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells,” Stem Cells, vol. 26, no. 2, pp. 300–311, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. M. B. Koh and G. Suck, “Cell therapy: promise fulfilled?” Biologicals : journal of the International Association of Biological Standardization, vol. 40, no. 3, pp. 214–217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. D. C. Ding, W. C. Shyu, and S. Z. Lin, “Mesenchymal stem cells,” Cell Transplantation, vol. 20, no. 1, pp. 5–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Musaro, K. McCullagh, A. Paul et al., “Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle,” Nature Genetics, vol. 27, no. 2, pp. 195–200, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Musaro, C. Giacinti, G. Borsellino et al., “Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, pp. 1206–1210, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Ren, P. Yin, and C. Duan, “IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop,” The Journal of Cell Biology, vol. 182, no. 5, pp. 979–991, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Grimberg and P. Cohen, “Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis,” Journal of Cellular Physiology, vol. 183, no. 1, pp. 1–9, 2000. View at Publisher · View at Google Scholar
  41. A. G. Miller, J. D. Aplin, and M. Westwood, “Adenovirally-mediated expression of insulin-like growth factors enhances the function of first trimester placental fibroblasts,” The Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 1, pp. 379–385, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Gabbitas and E. Canalis, “Growth factor regulation of insulin-like growth factor binding protein-6 expression in osteoblasts,” Journal of Cellular Biochemistry, vol. 66, no. 1, pp. 77–86, 1997. View at Publisher · View at Google Scholar
  43. L. A. Silverman, Z. Q. Cheng, D. Hsiao, and S. M. Rosenthal, “Skeletal muscle cell-derived insulin-like growth factor (IGF) binding proteins inhibit IGF-I-induced myogenesis in rat L6E9 cells,” Endocrinology, vol. 136, no. 2, pp. 720–726, 1995. View at Publisher · View at Google Scholar
  44. J. R. Florini, K. A. Magri, D. Z. Ewton, P. L. James, and K. Grindstaff, ““Spontaneous” differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II,” The Journal of Biological Chemistry, vol. 266, no. 24, pp. 15917–15923, 1991. View at Google Scholar
  45. Z. Wang, E. Oron, B. Nelson, S. Razis, and N. Ivanova, “Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells,” Cell Stem Cell, vol. 10, no. 4, pp. 440–454, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Radzisheuskaya, B. Chia Gle, R. L. dos Santos et al., “A defined Oct4 level governs cell state transitions of pluripotency entry and differentiation into all embryonic lineages,” Nature Cell Biology, vol. 15, no. 6, pp. 579–590, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. L. A. Bach, S. Hsieh, A. L. Brown, and M. M. Rechler, “Recombinant human insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts,” Endocrinology, vol. 135, no. 5, pp. 2168–2176, 1994. View at Publisher · View at Google Scholar · View at Scopus
  48. J. A. Toretsky and L. J. Helman, “Involvement of IGF-II in human cancer,” The Journal of Endocrinology, vol. 149, pp. 367–372, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Seurin, C. Lassarre, G. Bienvenu, and S. Babajko, “Insulin-like growth factor binding protein-6 inhibits neuroblastoma cell proliferation and tumour development,” European Journal of Cancer, vol. 38, no. 15, pp. 2058–2065, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. P. Grellier, D. Berrebi, M. Peuchmaur, and S. Babajko, “The IGF system in neuroblastoma xenografts: focus on IGF-binding protein-6,” The Journal of Endocrinology, vol. 172, no. 3, pp. 467–476, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. V. K. Han and A. M. Carter, “Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals,” Placenta, vol. 21, pp. 289–305, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. C. T. Roberts, J. A. Owens, and A. N. Sferruzzi-Perri, “Distinct actions of insulin-like growth factors (IGFs) on placental development and fetal growth: lessons from mice and guinea pigs,” Placenta, vol. 29, pp. S42–S47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. K. G. Pringle, K. L. Kind, A. N. Sferruzzi-Perri, J. G. Thompson, and C. T. Roberts, “Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy,” Human Reproduction Update, vol. 16, pp. 415–431, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. D. Aboalola, “Building muscle: the role of insulin-like growth factor binding protein-6 and insulin-like growth factors in the differentiation of placental mesenchymal stem cells into skeletal muscle,” Electronic Thesis and Dissertation Repository, vol. 2017, p. 4557, 2017. View at Google Scholar